Add Yahoo as a preferred source to see more of our stories on Google. Visual alarms in the OIRD feature alert clinicians to condition changes and escalate as a patient’s risk increases. Credit: Masimo ...

This clearance represents the first implementation of Masimo’s OIRD detection capability in a hospital monitoring solution. By combining the trusted signal quality of best-in-class Masimo SET ® with ...

Adam Szetela’s That Book Is Dangerous! examines the emergence of a new job in publishing—secondary readers who comb through books for possible offenses. Louis Marcoussis, Le lecteur, 1937. As a ...

Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced ...

One thing I’ve learned over the years as a clinical psychologist is that psychological research would be nothing without clinical input. Scientific research should be driven by theory, and theory does ...

NICU Study Adds to the Evidence Demonstrating SET®’s Accuracy in Challenging Real-World Settings, With No Clinically Significant Differences in Performance Across Skin Pigmentation Categories or Race ...

Masimo Corp. today reported study data showing that its pulse oximetry technology accurately monitored hospitalized newborns of all skin tones without dangerous drops in blood oxygen. The findings ...

Apple can keep selling Apple Watches with its redesigned blood oxygen feature in the US after the ITC declined to revive Masimo’s ban. Apple has secured a significant victory in its years-long dispute ...

Welcome to this week’s PPC Pulse. This week’s updates focus on Performance Max visibility improvements, new budget planning tools in Google Analytics, and generative video now built directly into ...

“The Federal Circuit [said] that the ITC permissibly treated the Masimo Watch as the domestic industry article and reasonably viewed the prototype units as physical articles practicing the asserted ...

NYSE:MS: $24.27 million (15.6% of AUM) NASDAQ:AMZN: $15.30 million (9.8% of AUM) NYSE:TEVA: $11.47 million (7.4% of AUM) NYSE:NKE: $11.45 million (7.4% of AUM) NYSE:ALC: $8.53 million (5.5% of AUM) As ...